Norepinephrine reuptake inhibitors and methods of using the same
CA 2643231 A1 · Owner: Ahmed, Saeeduddin · Inventors: Mcarthur, Robert; Cetera, Pasquale; Marshall, Robert Clyde
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and compositions for treating humans suffering from or , preventing a human from suffering a physiological or psychiatric disease disorder, or a , condition wherein inhibiting reuptake of norepinephrine is a benefit are disclosed. The , compositions may comprise a compound having a pharmacological selectivity of serotonin , (K i)/norepinephrine (K i) of at least about 5000. A preferred embodiment of a composition , according to the invention comprises racemic reboxetine. The methods generally include , administration of a therapeutic amount of such compositions. Also disclosed are , preparations of a medicament from the composition and uses of the composition , in a , …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 22, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 22, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 22, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.